Tag Archives: cardiovascular disease

December, 2016

October, 2016

October, 2015

  • 12 October

    Lilly Discontinues Development of its Experimental Cholesterol Drug

    INDIANAPOLIS, Oct. 12, 2015 /PRNewswire/ — Eli Lilly and Company and the ACCELERATE study’s academic leadership have accepted the recommendation of the independent data monitoring committee to terminate the Phase 3 trial of the investigational medicine evacetrapib, due to insufficient efficacy. Lilly will discontinue development of evacetrapib for the treatment of …

August, 2015

  • 28 August

    FDA Approves Amgen’s PCSK9 Inhibitor Repatha

    The U.S. Food and Drug Administration today approved Repatha (evolocumab) injection for some patients who are unable to get their low-density lipoprotein (LDL) cholesterol under control with current treatment options. Repatha, the second drug approved in a new class of drugs known as PCSK9 inhibitors, is approved for use in addition to …